Compare $BIVI vs $PHIO | Chartloom

Compare

$BIVI vs $PHIO

BioVie Inc · Phio Pharmaceuticals Corp

BIVI

BioVie Inc

PHIO

Phio Pharmaceuticals Corp

Compare $BIVI vs $PHIO

Comparing BioVie Inc and Phio Pharmaceuticals Corp

BIVIBioVie Inc

PHIOPhio Pharmaceuticals Corp

BIVIBioVie Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

4.5%

52W performance

-29.4%

FCF yield

-181.5%

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIVI

PHIO

Detailed metrics comparison

BIVI

BioVie Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

BIVI$10M

PHIO$11M

Enterprise Value

BIVI$2M

PHIO$-2M

Price

BIVI$1.39

PHIO$0.98

P/E Ratio

BIVIN/A

PHION/A

P/S Ratio

BIVI0.00x

PHIO81.74x

EV/Sales

BIVI0.00x

PHIO-11.08x

EV/EBITDA

BIVI0.00x

PHIO0.00x

P/B Ratio

BIVI1.21x

PHIO0.91x

P/FCF Ratio

BIVIN/A

PHION/A

EV/FCF

BIVI-0.08x

PHIO0.13x

PEG Ratio

BIVIN/A

PHION/A

Forward P/E (NTM)

BIVIN/A

PHION/A

Forward P/S (NTM)

BIVIN/A

PHION/A

Revenue (TTM)

BIVI$0

PHIO$0

Revenue Growth (YoY)

BIVIN/A

PHION/A

Forward Rev Growth

BIVI0.0%

PHIO0.0%

Gross Margin (TTM)

BIVI0.0%

PHIO0.0%

Operating Margin (TTM)

BIVI0.0%

PHIO0.0%

EBITDA Margin (TTM)

BIVI0.0%

PHIO0.0%

Net Margin (TTM)

BIVI0.0%

PHIO0.0%

FCF Margin (TTM)

BIVIN/A

PHION/A

Net Income (TTM)

BIVI$-22M

PHIO$-13M

FCF (TTM)

BIVI$-19M

PHIO$-12M

EPS (TTM)

BIVI-$2.79

PHIO-$1.11

ROE (TTM)

BIVI-12602.0%

PHIO-8741.0%

ROA (TTM)

BIVI-10888.0%

PHIO-7976.0%

ROIC (TTM)

BIVI-12602.0%

PHIO-8741.0%

Cash

BIVI$9M

PHIO$13M

Debt

BIVI$0

PHIO$0

Net Cash/Debt

BIVI$9M

PHIO$13M

Current Ratio (TTM)

BIVI3.59x

PHIO8.39x

Quick Ratio (TTM)

BIVI2.93x

PHIO7.62x

Debt/Equity (TTM)

BIVI0.00x

PHIO0.00x

Debt/Assets (TTM)

BIVI0.0%

PHIO0.0%

Interest Coverage (TTM)

BIVIN/A

PHION/A

Net Debt/EBITDA (TTM)

BIVI0.00x

PHIO0.00x

Beta

BIVI0.84

PHIO0.90

52W Performance

BIVI-29.4%

PHIO-59.6%

YTD Performance

BIVI4.5%

PHIO-10.2%

% from 52W High

BIVI-63.3%

PHIO-76.6%

% from 52W Low

BIVI69.5%

PHIO20.8%

Asset Turnover (TTM)

BIVI0.00x

PHIO0.02x

FCF Yield (TTM)

BIVI-181.5%

PHIO-107.3%

Earnings Yield (TTM)

BIVI-211.0%

PHIO-113.5%

Dividend Yield (TTM)

BIVIN/A

PHION/A

Rule of 40

BIVI0.0

PHIO0.0

EV/GP/RG

BIVIN/A

PHION/A

Ticker research

View BIVI research View PHIO research

Metric	BIVI BioVie Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$10M	$11M
Enterprise Value	$2M	$-2M
Price	$1.39	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.21x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.08x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-13M
FCF (TTM)	$-19M	$-12M
EPS (TTM)	-$2.79	-$1.11
ROE (TTM)	-12602.0%	-8741.0%
ROA (TTM)	-10888.0%	-7976.0%
ROIC (TTM)	-12602.0%	-8741.0%
Financial Health
Cash	$9M	$13M
Debt	$0	$0
Net Cash/Debt	$9M	$13M
Current Ratio (TTM)	3.59x	8.39x
Quick Ratio (TTM)	2.93x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.84	0.90
52W Performance	-29.4%	-59.6%
YTD Performance	4.5%	-10.2%
% from 52W High	-63.3%	-76.6%
% from 52W Low	69.5%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-181.5%	-107.3%
Earnings Yield (TTM)	-211.0%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIVI research	View PHIO research

Valuation

P/S Ratio

BIVI

0.00x

PHIO

81.74x

EV/FCF

BIVI

-0.08x

PHIO

0.13x

Growth & revenue

Forward Revenue Growth

BIVI

0.0%

PHIO

0.0%

Profitability & performance

Gross Margin

BIVI

0.0%

PHIO

0.0%

ROE

PHIO

-8741.0%

BIVI

-12602.0%

FCF Yield %

PHIO

-107.3%

BIVI

-181.5%

52-Week Performance

BIVI

-29.4%

PHIO

-59.6%

Detailed metrics comparison

BIVI

BioVie Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

BIVI$10M

PHIO$11M

Enterprise Value

BIVI$2M

PHIO$-2M

Price

BIVI$1.39

PHIO$0.98

P/E Ratio

BIVIN/A

PHION/A

P/S Ratio

BIVI0.00x

PHIO81.74x

EV/Sales

BIVI0.00x

PHIO-11.08x

EV/EBITDA

BIVI0.00x

PHIO0.00x

P/B Ratio

BIVI1.21x

PHIO0.91x

P/FCF Ratio

BIVIN/A

PHION/A

EV/FCF

BIVI-0.08x

PHIO0.13x

PEG Ratio

BIVIN/A

PHION/A

Forward P/E (NTM)

BIVIN/A

PHION/A

Forward P/S (NTM)

BIVIN/A

PHION/A

Revenue (TTM)

BIVI$0

PHIO$0

Revenue Growth (YoY)

BIVIN/A

PHION/A

Forward Rev Growth

BIVI0.0%

PHIO0.0%

Gross Margin (TTM)

BIVI0.0%

PHIO0.0%

Operating Margin (TTM)

BIVI0.0%

PHIO0.0%

EBITDA Margin (TTM)

BIVI0.0%

PHIO0.0%

Net Margin (TTM)

BIVI0.0%

PHIO0.0%

FCF Margin (TTM)

BIVIN/A

PHION/A

Net Income (TTM)

BIVI$-22M

PHIO$-13M

FCF (TTM)

BIVI$-19M

PHIO$-12M

EPS (TTM)

BIVI-$2.79

PHIO-$1.11

ROE (TTM)

BIVI-12602.0%

PHIO-8741.0%

ROA (TTM)

BIVI-10888.0%

PHIO-7976.0%

ROIC (TTM)

BIVI-12602.0%

PHIO-8741.0%

Cash

BIVI$9M

PHIO$13M

Debt

BIVI$0

PHIO$0

Net Cash/Debt

BIVI$9M

PHIO$13M

Current Ratio (TTM)

BIVI3.59x

PHIO8.39x

Quick Ratio (TTM)

BIVI2.93x

PHIO7.62x

Debt/Equity (TTM)

BIVI0.00x

PHIO0.00x

Debt/Assets (TTM)

BIVI0.0%

PHIO0.0%

Interest Coverage (TTM)

BIVIN/A

PHION/A

Net Debt/EBITDA (TTM)

BIVI0.00x

PHIO0.00x

Beta

BIVI0.84

PHIO0.90

52W Performance

BIVI-29.4%

PHIO-59.6%

YTD Performance

BIVI4.5%

PHIO-10.2%

% from 52W High

BIVI-63.3%

PHIO-76.6%

% from 52W Low

BIVI69.5%

PHIO20.8%

Asset Turnover (TTM)

BIVI0.00x

PHIO0.02x

FCF Yield (TTM)

BIVI-181.5%

PHIO-107.3%

Earnings Yield (TTM)

BIVI-211.0%

PHIO-113.5%

Dividend Yield (TTM)

BIVIN/A

PHION/A

Rule of 40

BIVI0.0

PHIO0.0

EV/GP/RG

BIVIN/A

PHION/A

Ticker research

View BIVI research View PHIO research

Metric	BIVI BioVie Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$10M	$11M
Enterprise Value	$2M	$-2M
Price	$1.39	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.21x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.08x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-13M
FCF (TTM)	$-19M	$-12M
EPS (TTM)	-$2.79	-$1.11
ROE (TTM)	-12602.0%	-8741.0%
ROA (TTM)	-10888.0%	-7976.0%
ROIC (TTM)	-12602.0%	-8741.0%
Financial Health
Cash	$9M	$13M
Debt	$0	$0
Net Cash/Debt	$9M	$13M
Current Ratio (TTM)	3.59x	8.39x
Quick Ratio (TTM)	2.93x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.84	0.90
52W Performance	-29.4%	-59.6%
YTD Performance	4.5%	-10.2%
% from 52W High	-63.3%	-76.6%
% from 52W Low	69.5%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-181.5%	-107.3%
Earnings Yield (TTM)	-211.0%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIVI research	View PHIO research